Exercise-induced lowering of fetuin-A may increase hepatic insulin sensitivity

Medicine and Science in Sports and Exercise

Volumn 46, Issue 11, 2014, Pages 2085-2090

  Malin, Steven K ^a,b   Del Rincon, Juan Pablo ^a   Huang, Hazel ^a   Kirwan, John P ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Exercise training; Glucose tolerance; Inflammation; Obesity

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; FETUIN A; LEPTIN;

AGED; BLOOD; BODY FAT DISTRIBUTION; EXERCISE; FEMALE; HUMAN; INSULIN RESISTANCE; LIVER; MALE; METABOLISM; OBESITY; PHYSIOLOGY; SKELETAL MUSCLE;

ADIPONECTIN; AGED; ALPHA-2-HS-GLYCOPROTEIN; BODY FAT DISTRIBUTION; C-REACTIVE PROTEIN; EXERCISE; FEMALE; HUMANS; INSULIN RESISTANCE; LEPTIN; LIVER; MALE; MUSCLE, SKELETAL; OBESITY;

EID: 84916897557     PISSN: 01959131     EISSN: 15300315     Source Type: Journal    
DOI: 10.1249/MSS.0000000000000338     Document Type: Article

References (27)

1. Auberger P, Falquerho L, Contreres JO, et al. Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and anti-mitogenic activity. Cell. 1989;58(4):631-40.
2. Blüher M, Rudich A, Klöting N, et al. Two patterns of adipokine and other biomarker dynamics in a long-term weight loss intervention. Diabetes Care. 2012;35(2):342-9.
3. Brons C, Jensen CB, Storgaard H, et al. Impact of short-term highfat feeding on glucose and insulin metabolism in young health men. J Physiol. 2009;15(587):2387-97.
4. Choi KM, Han KA, Ahn HJ, et al. The effects of caloric restriction on fetuin-A and cardiovascular risk factors in rats and humans: a randomized controlled trial. Clin Endocrinol (Oxf ). 2013;29(3):356-63.
5. Hennige AM, Staiger H, Wicke C, et al. Fetuin-A induces cytokine expression and suppresses adiponectin production. PLoS One. 2008;3(3):e1765.
6. Iwabu M, Yamauchi T, Okada-Iwabu M, et al. Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca(2+) and AMPK/SIRT1. Nature. 2010;464(7293):1313-9.
7. Ix JH, Sharma K. Mechanisms linking obesity, chronic kidney disease, and fatty liver disease: the roles of fetuin-A, adiponectin, and AMPK. J Am Soc Nephrol. 2010;21(3):406-12.
8. Jenkins NT, McKenzie JA, Hagberg JM, Witkowski S. Plasma fetuin-A concentrations in young and older high- and low-active men. Metabolism. 2011;60(2):265-71.
9. Jung TW, Young BS, Choi HY, et al. Salsalate and adiponectin ameliorate hepatic steatosis by inhibition of the hepatokine fetuin-A. Biochem Pharmacol. 2013;86(7):960-9.
10. Kelly KR, Blaszczak A, Haus JM, et al. A 7-d exercise program increases high-molecular weight adiponectin in obese adults. Med Sci Sports Exerc. 2012;44(1):69-74.
11. Kirk E, Reeds DN, Finck BN, Mayurranjan MS, Patterson BW, Klein S. Dietary fat and carbohydrate differentially alter insulin sensitivity during caloric restriction. Gastroenterology. 2009; 136(5):1552-60.
12. Lin X, Braymer HD, Bray GA, York DA. Differential expression of insulin receptor tyrosine kinase inhibitor (fetuin) gene in a model of diet-induced obesity. Life Sci. 1998;63(2):145-53.
13. Malin SK, Haus JM, Solomon TPJ, Blaszczak A, Kashyap SR, Kirwan JP. Insulin sensitivity and metabolic flexibility following exercise training among different obese insulin resistant phenotypes. Am J Physiol Endocrinol Metab. 2013;305(10):E1292-8.
14. Malin SK, Mulya A, Fealy CE, et al. Fetuin-A is linked to improved glucose tolerance after short-term exercise training in nonalcoholic fatty liver disease. J Appl Physiol (1985). 2013; 115(7):988-94.
15. Mathews ST, Rakhade S, Zhou X, Parker GC, Coscina DV, Grunberger G. Fetuin-null mice are protected against obesity and insulin resistance associated with aging. Biochem Biophys Res Commun. 2006;350(2):437-43.
16. Mathews ST, Singh GP, Ranalletta M, et al. Improved insulin sensitivity and resistance to weight gain in mice null for the Ahsg gene. Diabetes. 2002;51(8):2450-8.
17. Mori K, Emoto M, Araki T, et al. Effects of pioglitazone on serum fetuin-A levels in patients with type 2 diabetes mellitus. Metabolism. 2008;57(9):1248-52.
18. O'Leary VB, Jorett AE, Marchetti CM, et al. Enhanced adiponectin multimer ratio and skeletal muscle adiponectin receptor expression following exercise training and diet in older insulin-resistance adults. Am J Physiol Endocrinol Metab. 2007;293(1):E421-7.
19. Pal D, Dasgupta S, Kundu R, et al. Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance. Nat Med. 2012;18(8):1279-85.
20. Reinehr T, Roth CL. Fetuin-A and its relation to metabolic syndrome and fatty liver disease in obese children before and after weight loss. J Clin Endocrinol Metab. 2008;93(11): 4479-85.
21. Schultes B, Frick J, Ernst B, Stefan N, Fritsche A. The effect of 6-weeks of aerobic exercise training on serum fetuin-A levels in non-diabetic obese women. Exp Clin Endocrinol Diabetes. 2010;118(10):754-6.
22. Simpson KA, Singh MA. Effects of exercise on adiponectin: a systematic review. Obesity (Silver Spring). 2008;16(2):241-56.
23. Stefan N, Hennige AM, Staiger H, et al. Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care. 2006; 29(4):853-7.
24. Sutherland JP, McKinley B, Eckel RH. The metabolic syndrome and inflammation. Metab Syndr Relat Disord. 2004; 2(2):82-104.
25. Turner AT, Scherer PE. Adiponectin: mechanistic insights and clinical implications. Diabetologia. 2012;55(9):2319-26.
26. Yang SJ, Hong HC, Choi HY, et al. Effects of a three-month combined exercise programme on fibroblast growth factor 21 and fetuin-A levels and arterial stiffness in obese women. Clin Endocrinol (Oxf). 2011;75(4):464-9.
27. You T, Arsenis NC, Disanzo BL, LaMonte MJ. Effects of exercise training on chronic inflammation in obesity: current evidence and potential mechanisms. Sports Med. 2013;43(4):243-56.